Home » Public Policy

Letters, Testimony & Comments

BIO's letter to FL Governor Scott Regarding Substitution of Biosimilar Medicines
The Honorable Rick Scott Office of the Governor State of Florida 400 S. Monroe St. Tallahassee, FL 32399-0001 Dear Governor Scott...
May 8 2013
Letter Supporting Florida House Bill 365; Pertaining to requirements for pharmacist to dispense substitute biological product
Representative Matt Hudson Florida House of Representatives 402 South Monroe Street Tallahassee, FL 32399 Dear Representative Hudson...
February 1 2013
BIO Principles on Patient Safety in the Substitution of Biologic Products
Biologics are complex medicines manufactured from living organisms. Unlike traditional “small molecule” drugs, biologics are...
January 24 2013
Statement in Support Of North Dakota S.B. 2190
The Biotechnology Industry Organization (BIO) is the world’s largest biotechnology trade association. BIO represents more than 1,...
January 24 2013
Statement in Opposition to North Dakota S. 2066
The Biotechnology Industry Organization (BIO) is the world’s largest biotechnology trade association. BIO represents more than 1,...
January 24 2013
Statement in Support of Virginia H.B. 1422
In December 2012, Virginia House Delegate John M. O'Bannon, III introduced the Interchangeable biosimilar biological products bill (H...
January 10 2013
Letter to the Texas Health and Human Services Commission Regarding Proposed Specialty Pharmacy Rule
February 22, 2012 Texas Health and Human Services Commission Attn: Stacey Johnston Policy Analyst Medicaid/Children’s Health...
March 1 2012
Testimony in Support of Economic Development and Jobs for the Michigan Bioscience Industry
September 13, 2011
Economic Development and Jobs for the Michigan Bioscience Industry Michigan House and Senate Standings Committee on the Biosciences...
September 13 2011
Testimony on Rhode Island Labeling Bill
April 13, 2011
Testimony of the Biotechnology Industry Organization (BIO) Hearing of the House Committee on Health, Education and Welfare April 13,...
April 13 2011
BIO comments on Draft Environmental Assessment: Use of Genetically Modified, Glyphosate-Tolerant Soybeans and Corn on National Wildlife Refuge Lands in the Mountain-Prairie Region
March 4, 2011
Re: Draft Environmental Assessment: Use of Genetically Modified, Glyphosate-Tolerant Soybeans and Corn on National Wildlife Refuge Lands...
March 4 2011
Statement of Support for Montana SB218
February 1, 2011
"An Act establishing procedures for sampling plants protected by patent or other intellectual property laws; requiring mediation of...
February 1 2011
Letter to Commissioner Seth Bradstreet, III, State of Maine Department of Agriculture, Food and Rural Resources commenting on the "Rule Requiring Use of Best Management Practices for Growing Crops to Minimize Cross Contamination"
December 14, 2009
Comments on the “Rule Requiring Use of Best Management Practices for Growing Crops to Minimize Cross Contamination” Dear...
December 14 2009
International Conference on Harmonisation; Draft Guidance on Q10 Pharmaceutical Quality System
October 17, 2007
BIO's comments to the FDA (96 KB PDF)
October 17 2007
Required Notification of Possession/Non-Possession of Select Agents Deadline
August 8, 2002
BIO members should immediately become familiar with provisions of the Public Health Security and Bioterrorism Response Act of 2002 (Pub....
August 8 2002
Building biotech in Ohio, You can if you think you can
July 13, 2001
Dan Eramian, Vice President Communications Biotechnology Industry Organization Athersys Cleveland, Ohio July 13, 2001 Let me start...
July 13 2001

Letters, Testimony & Comments

BIO's letter to FL Governor Scott Regarding Substitution of Biosimilar Medicines
May 8 2013
The Honorable Rick Scott Office of the Governor State of Florida 400 S. Monroe St. Tallahassee, FL 32399-0001 Dear Governor Scott...
Letter Supporting Florida House Bill 365; Pertaining to requirements for pharmacist to dispense substitute biological product
February 1 2013
Representative Matt Hudson Florida House of Representatives 402 South Monroe Street Tallahassee, FL 32399 Dear Representative Hudson...
BIO Principles on Patient Safety in the Substitution of Biologic Products
January 24 2013
Biologics are complex medicines manufactured from living organisms. Unlike traditional “small molecule” drugs, biologics are...
Statement in Support Of North Dakota S.B. 2190
January 24 2013
The Biotechnology Industry Organization (BIO) is the world’s largest biotechnology trade association. BIO represents more than 1,...
Statement in Opposition to North Dakota S. 2066
January 24 2013
The Biotechnology Industry Organization (BIO) is the world’s largest biotechnology trade association. BIO represents more than 1,...
More Letters, Testimony & Comments →

Press Releases

BIO Releases Bioscience Economic Development Report and Guide
April 23 2013
The Biotechnology Industry Organization (BIO) released its “Bioscience Economic Development: Legislative...
Administration’s Budget Proposal Undercuts Development of Cures and Breakthroughs, and Hurts Job Growth
April 11 2013
Washington, D.C. (April 16, 2013) Washington, D.C. (April 16, 2013) – The Biotechnology Industry Organization...
Biosimilars Bill Seeks To Notify Patients & Doctors of Changes to Prescriptions
April 3 2013
Washington, D.C. (April 2, 2013) –  The Biotechnology Industry Organization (BIO) and BioFlorida commend...
Governor McDonnell Signs First in Nation Biosimilars Bill; Patients To Be Notified If Doctor's Prescription Changed
March 21 2013
Washington, D.C. (March 21, 2013) – The Biotechnology Industry Organization (BIO) commends Virginia Governor...
Ken Lisaius Named BIO's Vice President of Communications
January 23 2013
Washington, D.C. (January 23, 2013) –  The Biotechnology Industry Organization (BIO) announced that Ken...
More Press Releases →